Lisinopril Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg
Reference Brands: Prinivil, Zestril(US & EU)
Category: Medical Aid
Lisinopril tablets are ACE inhibitors that block the conversion of angiotensin I to angiotensin II, a vasoconstrictor. Benefits include lowering blood pressure, reducing the risk of strokes and heart attacks, and treating heart failure. They improve cardiovascular health, ease workload on the heart, and protect kidney function. Lisinopril Tablets is available in Tablet and strengths such as 2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Lisinopril Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Lisinopril Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Lisinopril tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and quality compliance with GMP standards. In the US, regulations are overseen by the FDA, while in the EU, EMA manages approval processes. These dossiers include clinical trial data, stability, manufacturing practices, and safety profiles. Lisinopril is widely prescribed for hypertension, heart failure, and kidney protection, with market authorization granted after rigorous evaluation. For detailed licensing, approved dossiers, and regulatory updates in global markets, visit Pharmatradz. Stay informed on the latest regulatory requirements for lisinopril and ensure compliance for market success.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lisinopril is used to treat high blood pressure (hypertension), heart failure, and to improve survival after a heart attack. It helps relax blood vessels, making it easier for the heart to pump blood, and lowers the risk of strokes, heart attacks, and kidney problems.
Lisinopril is a synthetic peptide derivative of lysine and a member of the ACE inhibitor (angiotensin-converting enzyme inhibitor) class. It’s chemically synthesized, not derived from natural sources.
Common trade names include: Zestril® (by AstraZeneca), Prinivil® (by Merck), Lisotec®, Carace®, and other regional brands.
AstraZeneca – Manufacturer of Zestril® Merck & Co.
The generic name is Lisinopril.
The main brand names are Zestril® and Prinivil®.
Zestril® is manufactured by AstraZeneca in the USA and UK.
Related Products
Lofexidine Hydrochloride
Strength:
0.18 mg
Form: Tablets
Reference Brands: Lucemyra (USA)
View Details
Maralixibat
Strength:
380 µg/mL
Form: Oral Solution
Reference Brands: Livmarli (USA/EU)
View Details
Quick Response Guaranteed | Verified Suppliers
